Trials / Unknown
UnknownNCT06033170
Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
Prospective, Single-Arm Confirmatory Clinical Investigation to Demonstrate the Effectiveness, Performance, and Safety of the Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Medtrade · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a post market prospective, single arm clinical investigation to continuously assess the safety performance and effectiveness of the Celox™ PPH as a uterine haemostatic tamponade treatment for uterine postpartum hemorrhage (PPH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CELOX™ PPH | Celox™ PPH is intended to be a physical haemostatic treatment for control and treatment of uterine postpartum hemorrhage (PPH) when conservative management is warranted. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2025-10-01
- First posted
- 2023-09-13
- Last updated
- 2023-09-13
Source: ClinicalTrials.gov record NCT06033170. Inclusion in this directory is not an endorsement.